When I wrote about emerging trends in med tech early last year, I certainly did not predict the pandemic or the shutdown. While COVID-19 has had an obviously enormous impact on the American economy and on investing in general, that impact has been less severe in the life sciences sector. COVID-19 has not dampened angel investing in life sciences, nor has it derailed the explosion of emerging growth companies in this sector; in fact, it is commonly believed that the life sciences sector in 2021 will significantly outperform its 2020 results.

2021 brings new positive growth conditions for life sciences companies, and some of 2020’s positive trends have continued and even accelerated in the life sciences space in 2021, fueling growth and investment. As it is not possible to separate business impact from legal issues in emerging growth life sciences companies, attorneys representing these clients should watch these trends carefully and get ahead of the related legal issues for their clients. This is clearly going to be a year where attorneys must assist their life sciences clients in getting ahead of changes in the legal, business and operational landscape.

The Data Revolution Gathers Steam